ANGLE plc, a world-leading liquid biopsy company, will be releasing its interim results for the six months ended 30 June 2023 on Thursday 7 September 2023. A meeting for analysts will be held at 11:00 am BST on the same day at the offices of FTI Consulting in London. A live webcast of the analyst meeting will be available on ANGLE's Investor Centre page, with Q&A participation reserved for analysts only. A recording of the webcast will be made available on ANGLE's website following the results meeting. ANGLE's commercial businesses focus on diagnostic products and clinical services, including the Parsortix® system for CTC analysis and custom assay development and clinical trial testing for pharma.